We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
IRON icon
76
Disc Medicine
IRON
$3.07B
$3.07B $79.88 0.64%
BEAM icon
77
Beam Therapeutics
BEAM
$3.06B
$3.06B $29.64 0.61%
NAMS icon
78
NewAmsterdam Pharma
NAMS
$3.03B
$3.03B $25.37 1.86%
ARQT icon
79
Arcutis Biotherapeutics
ARQT
$2.98B
$2.98B $23.68 0.08%
MBX
80
MBX Biosciences
MBX
$2.96B
$2.96B $61.50 0.13%
ZLAB icon
81
Zai Lab
ZLAB
$2.92B
$2.92B $26.01 3.67%
SLS icon
82
SELLAS Life Sciences
SLS
$2.84B
$2.84B $14.07 2.7%
ATAI icon
83
AtaiBeckley Inc
ATAI
$2.72B
$2.72B $7.33 0.14%
NRIX icon
84
Nurix Therapeutics
NRIX
$2.67B
$2.67B $25.68 1.42%
VRDN icon
85
Viridian Therapeutics
VRDN
$2.59B
$2.59B $22.82 0.61%
PGEN icon
86
Precigen
PGEN
$2.56B
$2.56B $7.16 0.28%
VERA icon
87
Vera Therapeutics
VERA
$2.55B
$2.55B $35.45 1.31%
PHVS icon
88
Pharvaris
PHVS
$2.53B
$2.53B $36.02 1.01%
NKTR icon
89
Nektar Therapeutics
NKTR
$2.53B
$2.53B $74.04 3.05%
MLYS icon
90
Mineralys Therapeutics
MLYS
$2.46B
$2.46B $27.81 1.63%
HRMY icon
91
Harmony Biosciences
HRMY
$2.45B
$2.45B $42.02 0.38%
TRVI icon
92
Trevi Therapeutics
TRVI
$2.44B
$2.44B $17.14 0.47%
NUVB icon
93
Nuvation Bio
NUVB
$2.37B
$2.37B $6.75 0.3%
BHVN icon
94
Biohaven
BHVN
$2.36B
$2.36B $15.60 1.64%
OCUL icon
95
Ocular Therapeutix
OCUL
$2.35B
$2.35B $10.70 0.56%
SRPT icon
96
Sarepta Therapeutics
SRPT
$2.34B
$2.34B $22.18 3.52%
PVLA
97
Palvella Therapeutics
PVLA
$2.24B
$2.24B $155.69 0.14%
RAPP
98
Rapport Therapeutics
RAPP
$2.24B
$2.24B $46.75 1.89%
MESO
99
Mesoblast
MESO
$2.24B
$2.24B $17.25 0.64%
KOD icon
100
Kodiak Sciences
KOD
$2.23B
$2.23B $35.49 2.39%
2 3
4
5 6

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 568 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.35T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $139B, Regeneron Pharmaceuticals (REGN) at $85.7B and argenx (ARGX) at $64.8B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 243 funds opened new positions, taking total fund holders up 177 (34%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.